Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
AP Images for Humana Inc.
Arlington Partners LLC acquired a new position in shares of Humana in the fourth quarter valued at $29,000.
Arlington Partners LLC bought a new stake in shares of Humana in the 4th quarter valued at approximately $29,000.
Source: https://www.dailypolitical.com/2023/01/23/humana-inc-nysehum-short-interest-update.html
Cigna and Humana are in talks for a combination that would create a new powerhouse in the health-insurance industry.
Finally, Key Financial Inc increased its stake in shares of Humana by 130.4% in the first quarter.
Health insurance giant Humana, which is based in Louisville, will discontinue its employer-sponsored programs over the next two years.
Humana climbed 5.6% after it topped expectations.
Humana Inc. has a one year low of $423.29 and a one year high of $541.21.
In June 2022, the FTC opened an into six large PBMs: CVS Caremark, Express Scripts, OptumRx, Humana, Prime Therapeutics, and MedImpact Healthcare Systems.
Jesse Gamez is the Utah Medicare president at Humana.
Source: https://www.deseret.com/opinion/2023/4/15/23680465/original-medicare-advantage-medicare-options
Meritage Portfolio Management acquired a new stake in shares of Humana in the 2nd quarter worth approximately $7,915,000.
More generally, I would just say that we don’t have any reason to think that the inherent error rate within the Humana population would be meaningfully different from others.
Providing coverage for upwards of twenty million Americans, Humana is one of the largest health insurance providers in the United States.
There are also local FEHB MA plans available from Humana, Kaiser, UnitedHealthcare, and UPMC that between them cover most states.
Source: https://www.govexec.com/pay-benefits/2023/03/medicare-part-d-changes-federal-annuitants/383469/
TheStreet raised Humana from a “c+” rating to a “b-” rating in a research note on Thursday, April 13th.